Timeless Capital Corp.
TTSXV:TLC.P0.02
CAD
-0.01
(-40.00%)
ISIN
CA8873331026
CUSIP
887333102
Return %
Stock
S&P 500
1Y
200.00
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
CAD
•
in mil. unless spec.Working Capital
CAD
•
in mil. unless spec.Growth Rates
CAD
•
in mil. unless spec.Quarterly Revenue
CAD
•
in mil. unless spec.Quarterly Earnings Per Share
CAD
•
in mil. unless spec.Quarterly Dividends Per Share
CAD
•
in mil. unless spec.Company Description
- CEO
- Blair Jordan
- Sector
- Finance
- Industry
- Financial conglomerates
- Address
- Calgary Canada
- IPO Date
- Oct 29, 2018
- Similar Companies
- Business
- Timeless Capital Corp. is a capital pool company (CPC) focused on identifying, evaluating, and negotiating the acquisition of operating businesses or commercial assets to complete a Qualifying Transaction on the TSX Venture Exchange. As a specialized financial vehicle within the capital markets industry, the corporation does not produce physical goods or maintain commercial operations; rather, its principal services and operational offerings comprise capital formation and public listing facilitation; corporate identification and due diligence assessment of prospective operating businesses; reverse takeover (RTO) and business combination structuring; target asset acquisition negotiation; and corporate governance, treasury management, and continuous regulatory disclosure administration under Canadian securities frameworks. The company targets emerging private companies, growth-stage enterprises, and corporate owners across various sectors seeking access to public equity capital and a listing on the TSX Venture Exchange. Incorporated in August 2018 and headquartered in Calgary, Alberta, Canada, Timeless Capital Corp. operates as an independent entity with no active subsidiaries. In recent major corporate developments, the company mutually terminated its definitive amalgamation agreement for a proposed Qualifying Transaction with biotechnology firm Renaissance BioScience Corp. due to unfavorable market conditions. Following the termination, the corporation completed a non-brokered private placement financing in November 2024, issuing 2,500,000 common shares to bolster working capital and sustain ongoing search activities. Additionally, the company initiated corporate governance adjustments in 2025, which included a Chief Executive Officer transition, board restructuring, and the grant of incentive stock options to officers and directors to support future acquisition initiatives.